Salt and hypertension

Nephrology

Volumn 15, Issue SUPPL. 2, 2010, Pages 49-52

  Ritz, Eberhard ^a  

^a Division Nephrology   (Germany)

Author keywords

Aldosterone; Cardiotonic steroids; Hypertension; Mendelian randomization; Sodium

Indexed keywords

GLYCOSAMINOGLYCAN; VASCULOTROPIN; VASCULOTROPIN C; SALT INTAKE; SODIUM CHLORIDE;

CONFERENCE PAPER; DIALYSIS; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; HYPERTENSION; KIDNEY GRAFT; NATRIURESIS; NEPHRON; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SALT INTAKE; SENSITIVITY ANALYSIS; SODIUM RETENTION; URINALYSIS; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; COMPLICATION; HYPERTENSION, RENAL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; SODIUM CHLORIDE; SODIUM CHLORIDE, DIETARY;

EID: 77952626143     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01311.x     Document Type: Conference Paper

References (39)

1. Bright R. Reports of Medical Cases.
2. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J. Hum. Hypertens. 2009 23 : 363 384.
3. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J. Am. Soc. Nephrol. 2006 17 : 331 335.
4. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005 111 : 1370 1376.
5. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J. Am. Soc. Nephrol. 2008 19 : 1983 1988.
6. Kestenbaum B, Rudser KD, de Boer IH et al. Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis. Ann. Intern. Med. 2008 148 : 501 508.
7. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T. Role of the kidney in primary hypertension: A renal transplantation study in rats. Am. J. Physiol. 1990 258 : F606 611.
8. Curtis JJ, Luke RG, Dustan HP et al. Remission of essential hypertension after renal transplantation. N. Engl. J. Med. 1983 309 : 1009 1015.
9. Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: In utero programming in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol. 2006 2 : 700 707.
10. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am. J. Hypertens. 1988 1 : 335 347.
11. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N. Engl. J. Med. 2003 348 : 101 108. (Pubitemid 36056716)
12. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int. 2006 69 : 671 678.
13. Manalich R, Reyes L, Herrera M, Melendi C, Fundora I. Relationship between weight at birth and the number and size of renal glomeruli in humans: A histomorphometric study. Kidney Int. 2000 58 : 770 773.
14. Lurbe E, Garcia-Vicent C, Torro I et al. First-year blood pressure increase steepest in low birthweight newborns. J. Hypertens. 2007 25 : 81 6.
15. Jarvelin MR, Sovio U, King V et al. Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort. Hypertension 2004 44 : 838 846.
16. Boudville N, Prasad GV, Knoll G et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann. Intern. Med. 2006 145 : 185 196.
17. de Boer MP, Ijzerman RG, de Jongh RT et al. Birth weight relates to salt sensitivity of blood pressure in healthy adults. Hypertension 2008 51 : 928 932.
18. Guyton AC. Physiologic regulation of arterial pressure. Am. J. Cardiol. 1961 8 : 401 407.
19. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. 1969. J. Am. Soc. Nephrol. 1999 10 : 2248 2258.
20. Elliott P, Marmot M, Dyer A et al. The INTERSALT study: Main results, conclusions and some implications. Clin. Exp. Hypertens. A 1989 11 : 1025 1034.
21. Titze J, Ritz E. Salt and its effect on blood pressure and target organ damage: New pieces in an old puzzle. J. Nephrol. 2009 22 : 177 189.
22. Elliott P, Walker LL, Little MP et al. Change in salt intake affects blood pressure of chimpanzees: Implications for human populations. Circulation 2007 116 : 1563 1568.
23. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N. Engl. J. Med. 2002 346 : 913 923.
24. Machnik A, Neuhofer W, Jantsch J et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 2009 15 : 545 552.
25. Woods LL, Weeks DA, Rasch R. Hypertension after neonatal uninephrectomy in rats precedes glomerular damage. Hypertension 2001 38 : 337 342.
26. Thomson SC, Deng A, Wead L, Richter K, Blantz RC, Vallon V. An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. J. Clin. Invest. 2006 116 : 1110 1116.
27. Makhanova N, Hagaman J, Kim HS, Smithies O. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension 2008 51 : 134 140.
28. Nowaczynski W, Oliver WJ, Neel JV. Serum aldosterone and protein-binding variables in Yanomama Indians: A no-salt culture as compared to partially acculturated Guaymi Indians. Clin. Physiol. Biochem. 1985 3 : 289 306.
29. Gross E, Rothstein M, Dombek S, Juknis HI. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients. Am. J. Kidney Dis. 2005 46 : 94 101.
30. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc. Natl. Acad. Sci. USA 2007 104 : 16281 16286.
31. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: Their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 2007 293 : C509 536.
32. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004 66 : 2454 2466.
33. Lichtstein D, Rosen H. Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function. Neurochem. Res. 2001 26 : 971 978.
34. Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 2001 37 : 462 466.
35. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM et al. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J. Hypertens. 1999 17 : 1179 1187.
36. Gonick HC, Ding Y, Vaziri ND et al. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin. Exp. Hypertens. 1998 20 : 617 627.
37. Fava C, Montagnana M, Rosberg L et al. Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum. Mol. Genet. 2008 17 : 413 418.
38. Al-Awqati Q. Evidence-based politics of salt and blood pressure. Kidney Int. 2006 69 : 1707 1708.
39. Sanchez-Castillo CP, Warrender S, Whitehead TP, James WP. An assessment of the sources of dietary salt in a British population. Clin. Sci. (Lond.) 1987 72 : 95 102.